Effect of ritonavir-induced cytochrome P450 3A4 inhibition on plasma fentanyl concentrations: a pharmacokinetic simulation
نویسندگان
چکیده
15 Background: Ritonavir inhibition of cytochrome p450 3A4 decreases the elimination 16 clearance of fentanyl by 67%. We used a pharmacokinetic model developed from published 17 data to simulate the effect of sample patient-controlled epidural labor analgesic regimens on 18 plasma fentanyl concentrations in the absence and presence of ritonavir-induced cytochrome 19 p450 3A4 inhibition. 20 Methods: Fentanyl absorption from the epidural space was modeled using tanks-in-series 21 delay elements. Systemic fentanyl disposition was described using a three-compartment 22 pharmacokinetic model. Parameters for epidural drug absorption were estimated by fitting the 23 model to reported plasma fentanyl concentrations measured after epidural administration. The 24 validity of the model was assessed by comparing predicted plasma concentrations after 25 epidural administration to published data. The effect of ritonavir was modeled as a 67% 26 decrease in fentanyl elimination clearance. Plasma fentanyl concentrations were simulated for 27 six sample patient-controlled epidural labor analgesic regimens over 24 h using ritonavir and 28 control models. Simulated data were analyzed to determine if plasma fentanyl concentrations 29 producing a 50% decrease in minute ventilation (6.1 ng/mL) were achieved. 30 Results: Simulated plasma fentanyl concentrations in the ritonavir group were higher than 31 those in the control group for all sample labor analgesic regimens. Maximum plasma fentanyl 32 concentrations were 1.8 ng/mL and 3.4 ng/mL for the normal and ritonavir simulations, 33 respectively, and did not reach concentrations associated with 50% decrease in minute 34 ventilation. 35 Conclusion: Our model predicts that even with maximal clinical dosing regimens of epidural 36 fentanyl over 24 h, ritonavir-induced cytochrome p450 3A4 inhibition is unlikely to produce 37 plasma fentanyl concentrations associated with a decrease in minute ventilation. 38 39
منابع مشابه
Characterization of Ritonavir-Mediated Inactivation of Cytochrome P450 3A4 s
Ritonavir is a human immunodeficiency virus (HIV) protease inhibitor and an inhibitor of cytochrome P450 3A4, the major human hepatic drug-metabolizing enzyme. Given the potent inhibition of CYP3A4 by ritonavir, subtherapeutic doses of ritonavir are used to increase plasma concentrations of other HIV drugs oxidized by CYP3A4, thereby extending their clinical efficacy. However, the mechanism of ...
متن کاملRitonavir analogues as a probe for deciphering the cytochrome P450 3A4 inhibitory mechanism.
Inactivation of human drug-metabolizing cytochrome P450 3A4 (CYP3A4) could lead to serious adverse events such as drug-drug interactions and toxicity. However, when properly controlled, CYP3A4 inhibition may be beneficial as it can improve clinical efficacy of co-administered therapeutics that otherwise are quickly metabolized by CYP3A4. Currently, the CYP3A4 inhibitor ritonavir and its derivat...
متن کاملFood consumption, cytochrome P450 3A4 (CYP3A4) presystemic inhibitors, and bioavailability of saquinavir.
It is accepted that the low bioavailability of orally administered saquinavir –SQV– (about 4% for the hard gelatin capsule or tablets –HGCT–, and about 12% for the soft gelatin capsule –SGC– when it is taken with food), is due to an incomplete intestinal absorption and to an extensive first-pass metabolism by cytochrome P450 3A4 (CYP3A4) in the gut and liver. As well, P-glycoprotein (P-gp), an ...
متن کاملCharacterization of ritonavir-mediated inactivation of cytochrome P450 3A4.
Ritonavir is a human immunodeficiency virus (HIV) protease inhibitor and an inhibitor of cytochrome P450 3A4, the major human hepatic drug-metabolizing enzyme. Given the potent inhibition of CYP3A4 by ritonavir, subtherapeutic doses of ritonavir are used to increase plasma concentrations of other HIV drugs oxidized by CYP3A4, thereby extending their clinical efficacy. However, the mechanism of ...
متن کاملFentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.
The synthetic opioid fentanyl undergoes extensive metabolism in humans. Systemic elimination occurs primarily by hepatic metabolism. When administered as a lozenge for oral transmucosal absorption, swallowed fentanyl is subject to first pass metabolism in the liver and possibly small intestine. Little is known, however, about the identity and formation of human fentanyl metabolites. This invest...
متن کامل